Innovation Platform

计划入组 640 人 · 首次发布于 2020 年 9 月 22 日

Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

A multicenter, randomized, double-blind, positive-controlled clinical trial to evaluate the efficacy and safety of Compound Yinhua Jiedu Granule in the treatment of influenza (wind-heat syndrome)

Microbiome Platform

IFO

RBOA

CSPC Innovation Pharmaceutical Co.,Ltd.

China

SOUND WAVE INNOVATION CO., LTD.

Japan

Innovation Medical Management Co .,Ltd.

China

CORE Biomedicine Secures $21 Million Series A and Eisai Licensing Deal to Advance Lineage-Based Precision Oncology Pipeline

Eisai Advances LEQEMBI Subcutaneous and IV Maintenance Dosing Applications for Alzheimer's Disease

AIM Vaccine Submits 13-Valent Pneumonia Conjugate Vaccine for Approval After Positive Phase III Results